Overview

An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR Compared to Mexiletine IR

Status:
RECRUITING

Trial end date:
2026-10-04

Target enrollment:

Participant gender:

Summary

An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR compared to Mexiletine IR in Patients with Non-Dystrophic Myotonias (ACHILLES study)

Phase:

PHASE3

Details

Lead Sponsor:

Lupin Ltd.

Collaborator:

Lupin Atlantis Holdings S.A.

Treatments:

Mexiletine